Skip to main content
  • Print publication year: 2017
  • Online publication date: December 2017

Chapter 32 - Neurologic Sequelae of Congenital and Perinatal Infections

from Section 4 - Specific Conditions Associated with Fetal and Neonatal Brain Injury
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Fetal and Neonatal Brain Injury
  • Online ISBN: 9781316275498
  • Book DOI:
Please enter your name
Please enter a valid email address
Who would you like to send this to *
1.Kenneson, A, Cannon, MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17: 253–76.
2.Manicklal, S, Emery, VC, Lazzarotto, T, et al. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26: 86102.
3.Dollard, SC, Grosse, SD, Ross, DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17: 355–63.
4.Stagno, S, Reynolds, DW, Huang, ES, et al. Congenital cytomegalovirus infection. N Engl J Med 1977; 296: 1254–8.
5.Saigal, S, Lunyk, O, Larke, RP, Chernesky, MA. The outcome in children with congenital cytomegalovirus infection: a longitudinal follow-up study. Am J Dis Child 1982; 136: 896901.
6.Fowler, KB, McCollister, FP, Dahle, AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130: 624–30.
7.Boppana, SB, Ross, SA, Fowler, KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 2013; 57(Suppl 4): S178–81.
8.Pass, RF, Stagno, S, Myers, GJ, Alford, CA. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 1980; 66: 758–62.
9.Boppana, SB, Fowler, KB, Vaid, Y, et al. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997; 99: 409–14.
10.Pass, RF, Anderson, B. Mother-to-child transmission of cytomegalovirus and prevention of congenital infection. J Pediatr Infect Dis Soc 2014; 3: S26.
11.Boppana, SB, Rivera, LB, Fowler, KB, et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344: 1366–71.
12.Monif, GR, Egan, EA 2nd, Held, B, Eitzman, DV. The correlation of maternal cytomegalovirus infection during varying stages in gestation with neonatal involvement. J Pediatr 1972; 80: 1720.
13.Reynolds, DW, Stagno, S, Stubbs, KG, et al. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels: casual relation with auditory and mental deficiency. N Engl J Med 1974; 290: 291–6.
14.Hanshaw, JB, Scheiner, AP, Moxley, AW, et al. School failure and deafness after “silent” congenital cytomegalovirus infection. N Engl J Med 1976; 295: 468–70.
15.Conboy, TJ, Pass, RF, Stagno, S, et al. Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection. Pediatrics 1986; 77: 801–6.
16.Williamson, WD, Demmler, GJ, Percy, AK, Catlin, FI. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992; 90: 862–6.
17.Dahle, AJ, Fowler, KB, Wright, JD, et al. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000; 11: 283–90.
18.Boppana, SB, Fowler, KB, Pass, RF, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005; 146: 817–23.
19.Forner, G, Abate, D, Mengoli, C, et al. High cytomegalovirus (CMV) DNAemia predicts CMV sequelae in asymptomatic congenitally infected newborns born to women with primary infection during pregnancy. J Infect Dis 2015; 212: 6771.
20.Stagno, S, Pass, RF, Cloud, G, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256: 1904–8.
21.Boppana, SB, Pass, RF, Britt, WJ, et al. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992; 11: 93–9.
22.Stagno, S, Pass, RF, Alford, CA. Perinatal infections and maldevelopment. Birth Defects Original Article Series 1981; 17: 3150.
23.McCracken, GH Jr, Shinefield, HM, Cobb, K, et al. Congenital cytomegalic inclusion disease: a longitudinal study of 20 patients. Am J Dis Child 1969; 117: 522–39.
24.Butt, W, Mackay, RJ, de Crespigny, LC, et al. Intracranial lesions of congenital cytomegalovirus infection detected by ultrasound scanning. Pediatrics 1984; 73: 611–4.
25.James, SH, Kimberlin, DW, Whitley, RJ. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res 2009; 83: 207–13.
26.Troendle Atkins, J, Demmler, GJ, Williamson, WD, et al. Polymerase chain reaction to detect cytomegalovirus DNA in the cerebrospinal fluid of neonates with congenital infection. J Infect Dis 1994; 169: 1334–7.
27.Noyola, DE, Demmler, GJ, Nelson, CT, et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2001; 138: 325–31.
28.Williamson, WD, Desmond, MM, LaFevers, N, et al. Symptomatic congenital cytomegalovirus: disorders of language, learning, and hearing. Am J Dis Child 1982; 136: 902–5.
29.Rivera, LB, Boppana, SB, Fowler, KB, et al. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 2002; 110: 762–7.
30.Kimberlin, DW, Lin, CY, Sanchez, PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143: 1625.
31.Kimberlin, DW, Jester, PM, Sanchez, PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015; 372: 933–43.
32.Wolf, A, Cowen, D, Paige, BH. Toxoplasmic encephalomyelitis. III. A new case of granulomatous encephalomyelitis due to a protozoon. Am J Pathol 1939; 15: 657–94.
33.McAuley, JB. Congenital toxoplasmosis. J Pediatr Infect Dis Soc 2014; 3: S30–5.
34.Lynfield, R, Guerina, NG. Toxoplasmosis. Pediatr Rev 1997; 18: 7583.
35.American Academy of Pediatrics. Toxoplasma gondii Infections. In Kimberlin, DW, Brady, MT, Jackson, MA, Long, SS, eds., Red Book: 2015 Report of the Committee on Infectious Diseases. Elk Grive Village, IL: American Academy of Pediatrics, 2015: 787–96.
36.Vogel, N, Kirisits, M, Michael, E, et al. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis 1996; 23: 1055–60.
37.Lindsay, DS, Dubey, JP. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology 2011; 138: 1829–31.
38.Hohlfeld, P, Daffos, F, Thulliez, P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989; 115: 765–9.
39.Foulon, W, Villena, I, Stray-Pedersen, B, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynecol 1999; 180: 410–5.
40.SYROCOT (Systematic Review on Congenital Toxoplasmosis) Study Group, Thiebaut, R, Leproust, S, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet 2007; 369: 115–22.
41.Prusa, AR, Kasper, DC, Pollak, A, et al. The Austrian Toxoplasmosis Register, 1992–2008. Clin Infect Dis 2015; 60: e410.
42.Hotop, A, Hlobil, H, Gross, U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2012; 54: 1545–52.
43.Cortina-Borja, M, Tan, HK, Wallon, M, et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 2010; 7.
44.Wallon, M, Peyron, F, Cornu, C, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis 2013; 56: 1223–31.
45.Koppe, JG, Loewer-Sieger, DH, de Roever-Bonnet, H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986; 1: 254–6.
46.Stagno, S, Reynolds, DW, Amos, CS, et al. Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and Toxoplasma infections. Pediatrics 1977; 59: 669–78.
47.Wilson, CB, Remington, JS, Stagno, S, Reynolds, DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980; 66: 767–74.
48.Guerina, NG, Hsu, HW, Meissner, HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994; 330: 1858–63.
49.Stillwaggon, E, Carrier, CS, Sautter, M, McLeod, R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Neglect Trop Dis 2011; 5: e1333.
50.Wong, SY, Remington, JS. Toxoplasmosis in pregnancy. Clin Infect Dis 1994; 18: 853–61; quiz 62.
51.McLeod, R, Boyer, K, Karrison, T, et al. Outcome of treatment for congenital toxoplasmosis, 1981–2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 2006; 42: 1383–94.
52.McAuley, J, Boyer, KM, Patel, D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994; 18: 3872.
53.Roizen, N, Swisher, CN, Stein, MA, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995; 95: 1120.
54.Patel, DV, Holfels, EM, Vogel, NP, et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology 1996; 199: 433–40.
55.Naessens, A, Jenum, PA, Pollak, A, et al. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr 1999; 135: 714–9.
56.Gilbert, RE, Thalib, L, Tan, HK, et al. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 2007; 14: 813.
57.Olariu, TR, Remington, JS, McLeod, R, et al. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 2011; 30: 1056–61.
58.Foulon, W, Pinon, JM, Stray-Pedersen, B, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 1999; 181: 843–7.
59.Wallon, M, Franck, J, Thulliez, P, et al. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol 2010; 115: 727–33.
60.Dudgeon, JA. Congenital rubella. J Pediatr 1975; 87: 1078–86.
61.Reef, SE, Frey, TK, Theall, K, et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 2002; 287: 464–72.
62.Centers for Disease Control and Prevention. Increase in rubella and congenital rubella syndrome – United States, 1988–1990. MMWR Morbid Mortal Wkly Rep 1991; 40: 93–9.
63.Achievements in public health: elimination of rubella and congenital rubella syndrome – United States, 1969–2004. Ann Pharmacother 2005; 39: 1151–2.
64.Centers for Disease Control and Prevention. Three cases of congenital rubella syndrome in the postelimination era – Maryland, Alabama, and Illinois, 2012. MMWR Morbid Mortal Wkly Rep 2013; 62:226–9.
65.Lambert, N, Strebel, P, Orenstein, W, et al. Rubella. Lancet 2015; 385: 2297–307.
66.Ujiie, M, Nabae, K, Shobayashi, T. Rubella outbreak in Japan. Lancet 2014; 383: 1460–1.
67.Miller, E, Cradock-Watson, JE, Pollock, TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2: 781–4.
68.Neu, N, Duchon, J, Zachariah, P. TORCH infections. Clin Perinatol 2015; 42: 77103.
69.Meitsch, K, Enders, G, Wolinsky, JS, et al. The role of rubella-immunoblot and rubella-peptide-EIA for the diagnosis of the congenital rubella syndrome during the prenatal and newborn periods. J Med Virol 1997; 51: 280–3.
70.Mace, M, Cointe, D, Six, C, et al. Diagnostic value of RT-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection. J Clin Microbiol 2004; 42: 4818–20.
71.Ueda, K, Nishida, Y, Oshima, K, Shepard, TH. Congenital rubella syndrome: correlation of gestational age at time of maternal rubella with type of defect. J Pediatr 1979; 94: 763–5.
72.Peckham, CS. Clinical and laboratory study of children exposed in utero to maternal rubella. Arch Dis Childhood 1972; 47: 571–7.
73.Frey, TK. Neurological aspects of rubella virus infection. Intervirology 1997; 40: 167–75.
74.Weil, ML, Itabashi, H, Cremer, NE, et al. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N Engl J Med 1975; 292: 994–8.
75.Macfarlane, DW, Boyd, RD, Dodrill, CB, Tufts, E. Intrauterine rubella, head size, and intellect. Pediatrics 1975; 55: 797801.
76.Chang, YC, Huang, CC, Liu, CC. Frequency of linear hyperechogenicity over the basal ganglia in young infants with congenital rubella syndrome. Clin Infect Dis 1996; 22: 569–71.
77.Lane, B, Sullivan, EV, Lim, KO, et al. White matter MR hyperintensities in adult patients with congenital rubella. Am J Neuroradiol 1996; 17: 99103.
78.Townsend, JJ, Baringer, JR, Wolinsky, JS, et al. Progressive rubella panencephalitis: late onset after congenital rubella. N Engl J Med 1975; 292: 990–3.
79.Desmond, MM, Fisher, ES, Vorderman, AL, et al. The longitudinal course of congenital rubella encephalitis in nonretarded children. J Pediatr 1978; 93: 584–91.
80.McIntosh, ED, Menser, MA. A fifty-year follow-up of congenital rubella. Lancet 1992; 340: 414–5.
81.Chess, S, Fernandez, P, Korn, S. Behavioral consequences of congenital rubella. J Pediatr 1978; 93: 699703.
82.Brown, AS, Cohen, P, Greenwald, S, Susser, E. Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry 2000; 157: 438–43.
83.Tanemura, M, Suzumori, K, Yagami, Y, Katow, S. Diagnosis of fetal rubella infection with reverse transcription and nested polymerase chain reaction: a study of 34 cases diagnosed in fetuses. Am J Obstet Gynecol 1996; 174: 578–82.
84.Reef, SE, Redd, SB, Abernathy, E, et al. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998–2004: the evidence for absence of endemic transmission. Clin Infect Dis 2006; 43(Suppl 3): S126–32.
85.Papania, MJ, Wallace, GS, Rota, PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr 2014; 168: 148–55.
86.McLean, HQ, Fiebelkorn, AP, Temte, JL, Wallace, GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 2013; 62: 134.
87.Klass, PE, Brown, ER, Pelton, SI. The incidence of prenatal syphilis at the Boston City Hospital: a comparison across four decades. Pediatrics 1994; 94: 24–8.
88.Wharton, M, Chorba, TL, Vogt, RL, et al. Case definitions for public health surveillance. MMWR Recommend Rep 1990; 39: 143.
89.Kwak, J, Lamprecht, C. A review of the guidelines for the evaluation and treatment of congenital syphilis. Pediatr Ann 2015; 44: e108–14.
90.Sung, L, MacDonald, NE. Syphilis: a pediatric perspective. Pediatr Rev 1998; 19: 1722.
91.Sanchez, PJ. Laboratory tests for congenital syphilis. Pediatr Infect Dis J 1998; 17: 70–1.
92.American Academy of Pediatrics. Syphilis. In: Kimberlin, DW, Brady, MT, Jackson, MA, Long, SS, eds., Red Book: 2015 Report of the Committee on Infectious Diseases. Elk Grove, IL: American Academy of Pediatrics, 2015: 755–68.
93.Stoll, BJ. Congenital syphilis: evaluation and management of neonates born to mothers with reactive serologic tests for syphilis. Pediatr Infect Dis J 1994; 13: 845–52; quiz 53.
94.Beeram, MR, Chopde, N, Dawood, Y, et al. Lumbar puncture in the evaluation of possible asymptomatic congenital syphilis in neonates. J Pediatr 1996; 128: 125–9.
95.Srinivasan, G, Ramamurthy, RS, Bharathi, A, et al. Congenital syphilis: a diagnostic and therapeutic dilemma. Pediatr Infect Dis 1983; 2: 436–41.
96.Sanchez, PJ, Wendel, GD Jr, Grimprel, E, et al. Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis 1993; 167: 148–57.
97.Michelow, IC, Wendel, GD Jr, Norgard, MV, et al. Central nervous system infection in congenital syphilis. N Engl J Med 2002; 346: 1792–8.
98.Fiumara, NJ, Lessell, S. Manifestations of late congenital syphilis: an analysis of 271 patients. Arch Dermatol 1970; 102: 7883.
99.Workowski, KA, Bolan, GA, CDC. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommend Rep 2015; 64: 1137.
100.Bialas, KM, Swamy, GK, Permar, SR. Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment. Clin Perinatol 2015; 42: 6175.
101.American College of Obstetricians and Gynecologists. Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy (Practice Bulletin No. 151). Obstet Gynecol 2015; 125: 1510–25.
102.Laforet, EG, Lynch, CL Jr. Multiple congenital defects following maternal varicella: report of a case. N Engl J Med 1947; 236: 534–7.
103.Pastuszak, AL, Levy, M, Schick, B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994; 330: 901–5.
104.Alkalay, AL, Pomerance, JJ, Rimoin, DL. Fetal varicella syndrome. J Pediatr 1987; 111: 320–3.
105.Enders, G, Miller, E, Cradock-Watson, J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343: 1548–51.
106.Jones, KL, Johnson, KA, Chambers, CD. Offspring of women infected with varicella during pregnancy: a prospective study. Teratology 1994; 49: 2932.
107.Scharf, A, Scherr, O, Enders, G, Helftenbein, E. Virus detection in the fetal tissue of a premature delivery with a congenital varicella syndrome: a case report. J Perinatal Med 1990; 18: 317–22.
108.Brunell, PA. Fetal and neonatal varicella-zoster infections. Semin Perinatol 1983; 7: 4756.
109.Wilson, E, Goss, MA, Marin, M, et al. Varicella vaccine exposure during pregnancy: data from 10 years of the pregnancy registry. J Infect Dis 2008; 197(Suppl 2): S178–84.
110.Ogilvie, MM. Antiviral prophylaxis and treatment in chickenpox: a review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36(Suppl 1): 31–8.
110a.Smith, CK, Arvin, AM. Varicella in the fetus and newborn. Semin Fetal Neonat Med 2009; 14: 209–17.
110b.Meyers, JD. Congenital varicella in term infants: risk reconsidered. J Infect Dis 1974; 129: 215–7.
111.Meyberg-Solomayer, GC, Fehm, T, Muller-Hansen, I, et al. Prenatal ultrasound diagnosis, follow-up, and outcome of congenital varicella syndrome. Fetal Diagn Ther 2006; 21: 296301.
112.Mouly, F, Mirlesse, V, Meritet, JF, et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 1997; 177: 894–8.
113.Brown, ZA, Wald, A, Morrow, RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203–9.
114.Kimberlin, DW. Herpes simplex virus infections of the newborn. Semin Perinatol 2007; 31: 1925.
115.James, SH, Kimberlin, DW. Neonatal herpes simplex virus infection: epidemiology and treatment. Clin Perinatol 2015; 42: 4759.
116.Jones, CA, Raynes-Greenow, C, Issacs, D. Population-based surveillance of neonatal HSV infection in Australia (1997–2011). Clin Infect Dis 2014; 59(4): 525–31.
117.James, SH, Sheffield, JS, Kimberlin, DW. Mother-to-child transmission of herpes simplex virus. J Pediatr Infect Dis Soc 2014; 3: S1923.
118.Brown, ZA, Benedetti, J, Ashley, R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991; 324: 1247–52.
119.Hutto, C, Arvin, A, Jacobs, R, et al. Intrauterine herpes simplex virus infections. J Pediatr 1987; 110: 97101.
120.Vasileiadis, GT, Roukema, HW, Romano, W, et al. Intrauterine herpes simplex infection. Am J Perinatol 2003; 20: 55–8.
121.Kimberlin, DW, Lin, CY, Jacobs, RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108: 223–9.
122.Kimberlin, DW. Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes 2007; 14: 11–6.
123.Whitley, R, Arvin, A, Prober, C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991; 324: 444–9.
124.Whitley, R, Arvin, A, Prober, C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991; 324: 450–4.
125.Kimberlin, D. Herpes simplex virus, meningitis and encephalitis in neonates. Herpes 2004; 11(Suppl 2): 65A76A.
126.Lakeman, FD, Whitley, RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995; 171: 857–63.
127.Kimberlin, DW, Lakeman, FD, Arvin, AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J Infect Dis 1996; 174: 1162–7.
128.Kimberlin, DW, Whitley, RJ, Wan, W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011; 365: 1284–92.
129.Whitley, RJ, Nahmias, AJ, Soong, SJ, et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980; 66: 495501.
130.Kimberlin, DW, Lin, CY, Jacobs, RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108: 230–8.
131.James, SH, Kimberlin, DW. Neonatal herpes simplex virus infection. Infect Dis Clin North Am 2015; 29(3): 391400.
132.American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists: management of herpes in pregnancy (Practice Bulletin No. 82). Obstet Gynecol 2007; 109: 1489–98.
133.Arvin, AM, Hensleigh, PA, Prober, CG, et al. Failure of antepartum maternal cultures to predict the infant’s risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986; 315: 796800.
134.American Academy of Pediatrics. Herpes Simplex. In Kimberlin, DW, Brady, MT, Jackson, MA, Long, SS, eds., Red Book: 2015 Report of the Committee on Infectious Diseases. Oak Grove, IL: American Academy of Pediatrics, 2015: 432–45.